Popular Articles

California Warns Consumers Not To Eat Seng Chen PiMei Candy
Dr. Mark Horton, director of the California Department of Public Health (CDPH), warned consumers not to eat SENG Chen PiMei Candy, after tests by CDPH found unacceptable levels of lead. Consumers in possession of the candy should discard it immediately.
generic viagra online
Novavax Announces Selection Of A Respiratory Syncytial Virus Vaccine Candidate For Advanced Preclinical Studies
Novavax, Inc. (Nasdaq: NVAX) announced final selection of a Respiratory Syncytial Virus (RSV) vaccine candidate that will be advanced into additional preclinical studies to support an Investigational New Drug (IND) application. As previously announced, Novavax has been evaluating a number of RSV vaccine candidates, all of which have successfully induced antibody responses in mice. Novavax scientists have now engineered a new vaccine candidate which has been shown to protect mice against RSV disease and can be produced at sufficient yields to allow commercial manufacture. This new candidate is directed against a protein on the surface of the virus, the "F" or "fusion" protein, which is the protein that the virus uses to infect and fuse with cells in the respiratory tract and cause disease.
News of the day
Philips Introduces Mobile C-arm With Flat Detector For Surgical X-ray Procedures
With rapid change taking place in the surgical environment as the range of interventional and minimally invasive procedures continues to expand, Royal Philips Electronics (AEX: PHI, NYSE: PHG) today announced the availability of the Veradius X-ray system. A mobile C-arm with a super thin, flat detector, Philips Veradius is designed to give the surgeon more flexibility and to improve patient care by streamlining workflow and improving image quality. The system also includes an additional monitor on the C-arm stand, enabling the operator to have an unobstructed view of the live image.
Mental Health

Hyperferritinemia Is Another Surrogate Marker Of Advanced Liver Disease

High serum ferritin, being a hallmark of hereditary hemochromatosis , is frequently found in chronic hepatitis C, alcoholic or non-alcoholic steatohepatitis and non-alcoholic fatty liver disease patients . A study in Italy has investigated the link between ferritin and steatosis in a non-obese cohort of non-alcoholic patients. In southern European populations, high ferritin levels, after exclusion of diagnosis of HH, represent a risk factor for steatosis and clinical relevance, being associated with low platelet count. Patients with chronic hepatitis C virus (HCV) infection often have elevated serum iron indices, but these do not accurately reflect hepatic iron content, nor are they able to predict clinically important endpoints, such as progression of fibrosis and responsiveness to interferon-based regimens. Studies that attempt to link iron and the course of chronic hepatitis C have been inconclusive. In chronic hepatitis C, steatosis is a common histological finding, occurring in 30%-70% of such patients. The biological mechanism underlying steatosis in HCV infection is not definitively understood, and is considered to be multifactorial with metabolic mechanisms, including insulin resistance and iron overload. A research article published on May 7, 2009 in the World Journal of Gastroenterology addresses this problem. The research team led by Professor Licata from Gastroenterology and Hepatology Unit of Palermo University analyzed in a cross-sectional study, a cohort of non-obese, non-alcoholic patients with compensated chronic liver disease characterized by elevated serum ferritin levels, of varying etiology, excluding hemochromatosis, to reassess the link between hyperferritinemia and other markers of the metabolic syndrome, mainly steatosis. All data provide further evidence that hyperferritinemia might be another surrogate marker of advanced liver disease of any etiology. Reference: Licata A, Nebbia ME, Cabibbo G, Lo Iacono G, Barbaria F, Brucato V, Alessi N, Porrovecchio S, Di Marco V, Craxç¬ A, Cammç  C. Hyperferritinemia is a risk factor for steatosis in chronic liver disease. World J Gastroenterol 2009; 15(17): 2132-2138 http://www.wjgnet.com/1007-9327/15/2132.asp Correspondence to: Dr. Anna Licata, MD, Gastroenterology and Hepatology Unit, Department of Internal Medicine, University of Palermo, 90127 Palermo, Italy. Lin Tian World Journal of Gastroenterology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):